Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells

Antioxidants and Redox Signaling

Volumn 17, Issue 6, 2012, Pages 902-913

  Chiu Ugalde, Jazmin ^a   Wirth, Eva K ^a   Klein, Marc O ^b   Sapin, Remy ^c   Fradejas Villar, Noelia ^a   Renko, Kostja ^a   Schomburg, Lutz ^a   Köhrle, Josef ^a   Schweizer, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; 4 HYDROXYNONENAL; CATALASE; GLUTATHIONE PEROXIDASE; IODINE; IODINE DEIODINASE; SELENOENZYME; SELENOPROTEIN; SUPEROXIDE DISMUTASE; THYROID HORMONE; THYROTROPIN; TRANSFER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO DEVELOPMENT; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HOMEOSTASIS; IMMUNOHISTOCHEMISTRY; LIPID PEROXIDATION; MORPHOMETRICS; MOUSE; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; THYROID CELL; THYROID FUNCTION; THYROID GLAND; THYROID HORMONE BLOOD LEVEL;

ANIMALS; CATALASE; EPITHELIAL CELLS; FEMALE; GLUTATHIONE PEROXIDASE; IMMUNOHISTOCHEMISTRY; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; OXIDATIVE STRESS; PEROXIREDOXINS; SELENOPROTEINS; THIOREDOXIN-DISULFIDE REDUCTASE; THYROID GLAND;

MUS;

EID: 84863951015     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4055     Document Type: Article

References (40)

1. Arthur JR, Nicol F, Hutchinson AR, and Beckett GJ. The effects of selenium depletion and repletion on the metabolism of thyroid hormones in the rat. J Inorg Biochem 39: 101-108, 1990.
2. Blauwkamp MN, Yu J, Schin MA, Burke KA, Berry MJ, Carlson BA, Brosius FC, and Koenig RJ. Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice. BMC Nephrol 9: 7, 2008.
3. Bouchard M, Souabni A, and Busslinger M. Tissue-specific expression of cre recombinase from the Pax8 locus. Genesis 38: 105-109, 2004.
4. Carlson BA, Yoo MH, Tsuji PA, Gladyshev VN, and Hatfield DL. Mouse models targeting selenocysteine tRNA expression for elucidating the role of selenoproteins in health and development. Molecules 14: 3509-3527, 2009.
5. Chanoine JP, Safran M, Farwell AP, Dubord S, Alex S, Stone S, Arthur JR, Braverman LE, and Leonard JL. Effects of selenium deficiency on thyroid hormone economy in rats. Endocrinology 131: 1787-1792, 1992.
6. Chiu-Ugalde J, Theilig F, Behrends T, Drebes J, Sieland C, Subbarayal P, Kohrle J, Hammes A, Schomburg L, and Schweizer U. Mutation of megalin leads to urinary loss of selenoprotein P and selenium deficiency in serum, liver, kidneys and brain. Biochem J 431: 103-111, 2010.
7. Chomczynski P and Rymaszewski M. Alkaline polyethylene glycol-based method for direct PCR from bacteria, eukaryotic tissue samples, and whole blood. Biotechniques 40: 454, 456, 458, 2006.
8. Combs GF, Jr., Midthune DN, Patterson KY, Canfield WK, Hill AD, Levander OA, Taylor PR, Moler JE, and Patterson BH. Effects of selenomethionine supplementation on selenium status and thyroid hormone concentrations in healthy adults. Am J Clin Nutr 89: 1808-1814, 2009.
9. Conrad M and Schweizer U. Unveiling the molecular mechanisms behind selenium-related diseases through knockout mouse studies. Antioxid Redox Signal 12: 851-865, 2010.
10. De Felice M and Di Lauro R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25: 722-746, 2004.
11. Dickson RC and Tomlinson RH. Selenium in blood and human tissues. Clin Chim Acta 16: 311-321, 1967.
12. Downey CM, Horton CR, Carlson BA, Parsons TE, Hatfield DL, Hallgrimsson B, and Jirik FR. Osteo-chondroprogenitorspecific deletion of the selenocysteine tRNA gene, Trsp, leads to chondronecrosis and abnormal skeletal development: a putative model for Kashin-Beck disease. PLoS Genet 5: e1000616, 2009.
13. Dumitrescu AM, Di Cosmo C, Liao XH, Weiss RE, and Refetoff S. The syndrome of inherited partial SBP2 deficiency in humans. Antioxid Redox Signal 12: 905-920, 2010.
14. Duntas LH, Mantzou E, and Koutras DA. Effects of a six month treatment with selenomethionine in patients with autoimmune thyroiditis. Eur J Endocrinol 148: 389-393, 2003.
15. Flohé L, Gü nzler WA, and Schock HH. Glutathione peroxidase: a selenoenzyme. FEBS Lett 32: 132-134, 1973.
16. Friedrichs B, Tepel C, Reinheckel T, Deussing J, von Figura K, Herzog V, Peters C, Saftig P, and Brix K. Thyroid functions of mouse cathepsins B, K, and L. J Clin Invest 111: 1733-1745, 2003.
17. Gä rtner R, Gasnier BC, Dietrich JW, Krebs B, and Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab 87: 1687-1691, 2002.
18. Hatfield DL and Gladyshev VN. How selenium has altered our understanding of the genetic code. Mol Cell Biol 22: 3565-3576, 2002.
19. Kero J, Ahmed K, Wettschureck N, Tunaru S, Wintermantel T, Greiner E, Schutz G, and Offermanns S. Thyrocytespecific Gq/G11 deficiency impairs thyroid function and prevents goiter development. J Clin Invest 117: 2399-2407, 2007.
20. Kiermayer C, Conrad M, Schneider M, Schmidt J, and Brielmeier M. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate. Genesis 45: 11-16, 2007.
21. Kö hrle J, Jakob F, Contempre B, and Dumont JE. Selenium, the thyroid, and the endocrine system. Endocr Rev 26: 944-984, 2005.
22. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, and Gladyshev VN. Characterization of mammalian selenoproteomes. Science 300: 1439-1443, 2003.
23. Kumaraswamy E, Carlson BA, Morgan F, Miyoshi K, Robinson GW, Su D, Wang S, Southon E, Tessarollo L, Lee BJ, Gladyshev VN, Hennighausen L, and Hatfield DL. Selective removal of the selenocysteine tRNA [Ser]Sec gene (Trsp) in mouse mammary epithelium. Mol Cell Biol 23: 1477-1488, 2003.
24. Mansouri A, Chowdhury K, and Gruss P. Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 19: 87-90, 1998.
25. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 101: 4003-4008, 2004.
26. Rayman MP, Thompson AJ, Bekaert B, Catterick J, Galassini R, Hall E, Warren-Perry M, and Beckett GJ. Randomized controlled trial of the effect of selenium supplementation on thyroid function in the elderly in the United Kingdom. Am J Clin Nutr 87: 370-378, 2008.
27. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, and Hoekstra WG. Selenium: biochemical role as a component of glutathione peroxidase. Science 179: 588-590, 1973.
28. Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF, St. Germain DL, and Galton VA. Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147: 580-589, 2006.
29. Schomburg L, Dumitrescu AM, Liao XH, Bin-Abbas B, Hoeflich J, Kö hrle J, and Refetoff S. Selenium supplementation fails to correct the selenoprotein synthesis defect in subjects with SBP2 gene mutations. Thyroid 19: 277-281, 2009.
30. Schomburg L, Riese C, Michaelis M, Griebert E, Klein MO, Sapin R, Schweizer U, and Kö hrle J. Synthesis and metabolism of thyroid hormones is preferentially maintained in selenium-deficient transgenic mice. Endocrinology 147: 1306-1313, 2006.
31. Schomburg L, Schweizer U, Holtmann B, Flohe L, Sendtner M, and Kö hrle J. Gene disruption discloses role of selenoprotein P in selenium delivery to target tissues. Biochem J 370: 397-402, 2003.
32. Schweizer U, Chiu J, and Kö hrle J. Peroxides and peroxidedegrading enzymes in the thyroid. Antioxid Redox Signal 10: 1577-1592, 2008.
33. Schweizer U, Streckfuss F, Pelt P, Carlson BA, Hatfield DL, Kö hrle J, and Schomburg L. Hepatically derived selenoprotein P is a key factor for kidney but not for brain selenium supply. Biochem J 386: 221-226, 2005.
34. Schweizer U, Weitzel JM, and Schomburg L. Think globally: act locally. New insights into the local regulation of thyroid hormone availability challenge long accepted dogmas. Mol Cell Endocrinol 289: 1-9, 2008.
35. Seiler A, Schneider M, Fö rster H, Roth S, Wirth EK, Culmsee C, Plesnila N, Kremmer E, Radmark O, Wurst W, Bornkamm GW, Schweizer U, and Conrad M. Glutathione peroxidase 4 senses and translates oxidative stress into 12/15-lipoxygenase dependent-and AIF-mediated cell death. Cell Metab 8: 237-248, 2008.
36. Streckfuss F, Hamann I, Schomburg L, Michaelis M, Sapin R, Klein MO, Kö hrle J, and Schweizer U. Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochem Biophys Res Commun 337: 739-745, 2005.
37. Thomson CD, McLachlan SK, Grant AM, Paterson E, and Lillico AJ. The effect of selenium on thyroid status in a population with marginal selenium and iodine status. Br J Nutr 94: 962-968, 2005.
38. Wirth EK, Conrad M, Winterer J, Wozny C, Carlson BA, Roth S, Schmitz D, Bornkamm GW, Coppola V, Tessarollo L, Schomburg L, Kö hrle J, Hatfield DL, and Schweizer U. Neuronal selenoprotein expression is required for interneuron development and prevents seizures and neurodegeneration. FASEB J 24: 844-852, 2010.
39. Wirth EK, Roth S, Blechschmidt C, Hö lter SM, Becker L, Racz I, Zimmer A, Klopstock T, Gailus-Durner V, Fuchs H, Wurst W, Naumann T, Bräuer A, de AngelisMH, Kö hrle J, Grü ters A, and Schweizer U. Neuronal 3¢,3,5-triiodothyronine (T3) uptake and behavioral phenotype of mice deficient in Mct8, the neuronal T3 transporter mutated in Allan-Herndon-Dudley syndrome. J Neurosci 29: 9439-9449, 2009.
40. Zachara BA, Wlodarczyk Z, Masztalerz M, Adamowicz A, Gromadzinska J, and Wasowicz W. Selenium concentrations and glutathione peroxidase activities in blood of patients before and after allogenic kidney transplantation. Biol Trace Element Res 97: 1-13, 2004.